MIG
INFI

Mariner Investment Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Mariner Investment Group’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-119,100
Closed -$52K – 244
2015
Q1 		$52K Buy
+119,100
New +$1.82M 0.01% 152
2014
Q3 		– Sell
-20,000
Closed -$3K – 298
2014
Q2 		$3K Hold
20,000
– – ﹤0.01% 238
2014
Q1 		$17K Buy
+20,000
New +$268K ﹤0.01% 198

Other funds holding INFI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Mariner Investment Group's INFI Position: Q1 2016 in Review

Mariner Investment Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2016, closing a stake of 138,100 shares — an estimated $1.08M sold.

Mariner Investment Group first reported a position in INFI in Q1 2014 and held it in 8 quarters. The position peaked at $1.51M in Q2 2015. 117 funds tracked by Wall St. Rank hold INFI as of Q1 2016.

  • Mariner Investment Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Mariner Investment Group sold 138,100 Infinity Pharmaceuticals, Inc. shares in Q1 2016, an estimated $1.08M.
  • Mariner Investment Group first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2014 and held it in 8 quarters.
  • Mariner Investment Group's Infinity Pharmaceuticals, Inc. position peaked at $1.51M in Q2 2015.
  • 117 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2016.

Based on Mariner Investment Group's 13F filing for Q1 2016, filed 3 May 2016.